Tanvir Tabish

Tanvir Tabish has extensive experience in formulation development, particularly in gene therapy and biopharmaceuticals, with a notable career spanning multiple leading pharmaceutical companies. At Takeda, Tanvir held the position of Head of Formulation Development for Gene Therapy and Protein Modalities, leading strategic efforts within the Manufacturing Sciences organization. Prior roles include Group Leader of Formulation Research at GlaxoSmithKline, Deputy Head of Formulation Development at Shire, and Director of Early Formulation Development at AstraZeneca. Additional roles at Ipsen and Boehringer Ingelheim emphasized early-stage formulation and stability testing for breakthrough therapies. Tanvir's educational background includes a Master's degree in Virology from the University of Surrey.